Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL2474734

CCCC[N+](CCCC)(CCCC)CCCC.COC(=O)[O-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.55
SLC22A2 O15244 1/20 0.48
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
ALOX12 P18054 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CES2 O00748 4/20 0.42
CES1 P23141 4/20 0.42
EPHX1 P07099 2/20 0.42
DNM1 Q05193 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28668949 0.98 SLC22A1 (0.52) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
SCHEMBL2479923 0.93 SLC22A1 (0.56) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
SCHEMBL18044855 0.93 SLC22A1 (0.56) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
SCHEMBL31164028 0.93 SLC22A1 (0.56) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrahexylammonium SCHEMBL2475820 0.93 SLC22A1 (0.56) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
SCHEMBL16115134 0.93 SLC22A1 (0.56) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL29047722 0.86 SLC22A1 (0.55) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrapropylammonium SCHEMBL17438403 0.86 SLC22A1 (0.50) SLC22A1SLC22A2CES2CES1EPHX1
Tetrabuthylammonium SCHEMBL106861 0.85 SLC22A1 (0.67) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL15633043 0.85 SLC22A1 (0.48) SLC22A1SLC22A2ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819735-A Liquid crystal elastomer and preparation method thereof 江西科技师范大学 2023-03-21 CN claimed
EP-2977395-A1 HIGHLY REACTIVE, POLYURETHANE COMPOSITIONS CONTAINING URETDIONE GROUPS WHICH CONTAIN THE CARBONATE SALTS Evonik Degussa GmbH (DE) 2016-01-27 EP claimed
US-20160017179-A1 HIGH-REACTIVITY POLYURETHANE COMPOSITIONS CONTAINING URETDIONE GROUPS AND COMPRISING CARBONATE SALTS EVONIK DEGUSSA GMBH (DE) 2016-01-21 US claimed
US-12565588-B2 Coating composition and wood article manufactured therefrom Sherwin-Williams (Guangdong) New Material Co., Ltd. (CN) 2026-03-03 US disclosed
EP-4692150-A1 CURABLE COMPOSITION AND CURED PRODUCT OF SAME DIC Corporation (JP) 2026-02-11 EP disclosed
US-12534639-B2 Michael addition curable composition, coating composition containing the same, and coated article Sherwin-Williams (Guangdong) New Material Co., Ltd. (CN) 2026-01-27 US disclosed
EP-4217408-B1 MICHAEL ADDITION CURABLE COMPOSITION, COATING COMPOSITION CONTAINING THE SAME, AND COATED ARTICLE MADE THEREFROM SHERWIN WILLIAMS GUANGDONG NEW MAT CO LTD (CN) 2025-12-17 EP disclosed
US-20250277074-A1 CORROSION-RESISTANT PRIMER AND TOPCOAT COMPOSITION SWIMC LLC (US) 2025-09-04 US disclosed
US-12331143-B2 Corrosion-resistant primer and topcoat composition SWIMC LLC (US) 2025-06-17 US disclosed
EP-4540306-A1 MICHAEL ADDITION CURABLE COMPOSITION, ITS APPLICATION AND PROCESS FOR PREPARING MODIFIED EPOXY RESIN SUITABLE FOR THE SAME Guangdong Huarun Paints Co., Ltd. (CN) 2025-04-23 EP disclosed
EP-4460541-A1 CHEMICAL AGENT RESISTANT COMPOSITION SWIMC LLC (US) 2024-11-13 EP disclosed
WO-2010075232-A1 TUNABLE POLYMER COMPOSITIONS NOVOMER, INC. (US) 2010-07-01 WO disclosed
EP-0999206-B1 Process for producing alpha cyano acetic acid esters BASF AG (DE) 2002-09-18 EP disclosed
US-6130347-A REACTING MONOCHLOROACETIC ESTER WITH HYDROGEN CYANIDE IN BASE PRESENCE; CYANATION BASF AKTIENGESELLSCHAFT (DE) 2000-10-10 US disclosed
EP-0999206-A1 Process for producing alpha cyano acetic acid esters BASF AKTIENGESELLSCHAFT (DE) 2000-05-10 EP disclosed
EP-0671384-B1 Process for the preparation of 3-cyano-3,5,5,-trimethyl-cyclohexanone BASF AG (DE) 1999-11-03 EP disclosed
US-5516928-A REACTION OF ISOPHORONE AND HYDROGEN CYANIDE USING QUATERNARY AMMONIUM CATALYST BASF AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
EP-0671384-A1 Process for the preparation of 3-cyano-3,5,5,-trimethyl-cyclohexanone BASF AKTIENGESELLSCHAFT (DE) 1995-09-13 EP disclosed
US-4776929-A Process for production of quaternary ammonium hydroxides MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1988-10-11 US disclosed
EP-0269949-A2 Process for producing a high purity quaternary ammonium hydroxide MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1988-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534639-B2 Michael addition curable composition, coating composition containing the same, and coated article PCNA, ILK, MGMT SLC22A1 3938/4885SLC22A2 3834/4885ALDH1A1 313/4885
US-12565588-B2 Coating composition and wood article manufactured therefrom ITGAM, NOX4, FTO SLC22A1 3879/4885SLC22A2 3690/4885ALDH1A1 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.